Parkinson’s Disease Gene Present in a Third of All Human Cancer Types, U.K. Study Finds
Researchers at London’s Institute of Cancer Research have found that mutations in a Parkinson’s disease gene called PARK2 can be found in…
Articles by Joana Fernandes, PhD
Stimulating Specific Type of Neuron Could Restore Movement in Parkinson’s Longer, Study Reports
Stimulating a specific type of brain neuron could restore movement in Parkinson’s disease longer than other approaches, a study in…
Stress Hormone Could Help Treat Parkinson’s Disease, Study Reports
The stress hormone cortisol prevents dopaminergic neurons from dying by promoting the expression of parkin, a protein that is in short…
Researchers Discover Why Deep Brain Stimulation Causes Weight Gain in Parkinson’s Patients
Researchers have identified why patients with Parkinson’s disease gain weight after deep brain stimulation (DBS), a surgical procedure performed to…
Acorda to Focus on Developing Parkinson’s Treatments CVT-301, Tozadenant
Acorda Therapeutics, which recently announced a corporate restructuring, will focus on the late-stage development of its two therapies for Parkinson’s disease,…
Brain Cells Called Astrocytes Can Be Transformed into Dopamine-producing Neurons, Study Shows
Researchers have discovered a way to transform certain brain cells into the neurons that produce dopamine, a neurotransmitter whose loss…
Anavex Therapies Reverse Cognitive Defects in Mice, Suggesting Their Use for Parkinson’s
Anavex Life Sciences therapies reversed Alzheimer’s-related cognitive deficits in mice and improved processes connected with the disease, according to presentations…
Herantis Pharma Plans Clinical Trial in Sweden of Its Parkinson’s Therapy CDNF
Herantis Pharma will conduct a Phase 1-2 clinical trial in Sweden to investigate whether its experimental drug CDNF can…
People with Hepatitis B and C Are More Likely to Develop Parkinson’s Disease, Study Says
Hepatitis B and C patients are more likely to develop Parkinson’s disease (PD) than people without hepatitis, according to a…
Parkinson’s Therapy CVT-301 Doesn’t Alter Lung Function, Acorda Therapeutics Reports
Treating Parkinson’s disease with CVT-301 — an investigational, inhaled levodopa — causes no changes in lung function, according to results of two clinical…